For Industry
NCCN wishes to acknowledge the support of the many companies who share our goal of improving cancer care for patients we serve.
NCCN appreciates that supporting companies recognize NCCN's need for autonomy in the development of the content of NCCN resources.
The NCCN has developed an Oncology Research Program (ORP) to provide additional opportunities to investigators at NCCN Member Institutions and to facilitate the post-approval evaluation of innovative and promising therapies. The focus of the NCCN ORP is to identify significant research opportunities identified and agreed to by NCCN and participating pharmaceutical and biotechnology companies. The program facilitates investigator-initiated clinical research in these important areas at NCCN Member Institutions.
The NCCN Industry Advisory Roundtable is an important resource for the development and expansion of NCCN programs. NCCN gratefully acknowledges the support and commitment of these companies to the improvement of the treatments available to the patients whom we all serve. We also appreciate the recognition of NCCN's necessary autonomy in all decision-making regarding the conclusions, recommendations and outcomes of NCCN programs.
Organizations who are interested in supporting NCCN programs are encouraged to contact Lyn Fitzgerald, Manager, Business Development.
Organizations who are interested in exhibiting at NCCN programs are encouraged to contact Jennifer Tredwell, Advertising Manager.
Interested parties may submit scientific data to NCCN for consideration by the guidelines panels at their review meetings. In order to facilitate timely submission of information, NCCN has posted a tentative meeting schedule.
The National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system.
The National Comprehensive Cancer Network is an alliance of 21 of the world’s leading cancer centers, working together to develop treatment guidelines for most cancers, and dedicated to research that improves the quality, effectiveness, and efficiency of cancer care. NCCN offers a number of resources to give clinicians access to tools and knowledge that can help guide decision-making in the management of cancer.
|